Estimating complete cancer prevalence in Europe: validity of alternative vs standard completeness indexes.
Fiche publication
Date publication
avril 2023
Journal
Frontiers in oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Dr JOOSTE Valérie
Tous les auteurs :
Demuru E, Rossi S, Ventura L, Dal Maso L, Guzzinati S, Katalinic A, Lamy S, Jooste V, Di Benedetto C, De Angelis R,
Lien Pubmed
Résumé
Comparable indicators on complete cancer prevalence are increasingly needed in Europe to support survivorship care planning. Direct measures can be biased by limited registration time and estimates are needed to recover long term survivors. The completeness index method, based on incidence and survival modelling, is the standard most validated approach.
Mots clés
EUROCARE, Europe, SEER program, cancer prevalence, cancer registries, cancer survivors, cancer survivorship
Référence
Front Oncol. 2023 04 24;13:1114701